about
Acromegaly Quality of Life Questionnaire (AcroQoL)The risks of overlooking the diagnosis of secreting pituitary adenomasEpidemiology of acromegaly: review of population studies.Hypogonadism in patients with acromegaly: data from the multi-centre acromegaly registry pilot study.Clinical efficacy and safety results for dose escalation of somatostatin receptor ligands in patients with acromegaly: a literature review.Pituitary tumor transforming gene-1 haplotypes and risk of pituitary adenoma: a case-control study.Elevated serum growth hormone in a patient with Type 1 diabetes: a diagnostic dilemma.Clinical applications of somatostatin analogs for growth hormone-secreting pituitary adenomasAcromegaly: re-thinking the cancer risk.Using growth hormone levels to detect macroadenoma in patients with acromegaly.Familial acromegaly: a familial report and review of the literature.Accelerated Telomere Shortening in Acromegaly; IGF-I Induces Telomere Shortening and Cellular Senescence.Current pharmacotherapy for acromegaly: a review.Etiologic aspects and management of acromegaly.Gene therapy for pituitary tumors.Incidence and prevalence of acromegaly in a large US health plan databaseManagement of type 2 diabetes mellitus associated with pituitary gigantism.Pituitary adenomas in childhood: development and diagnosis.Cost of management of invasive growth hormone-secreting macroadenoma.Does acromegaly enhance mortality?Excess mortality in acromegaly.Current diagnosis of acromegaly.Risk of colorectal neoplasm in patients with acromegaly: a meta-analysis.Emerging drugs for acromegaly.Acromegaly: clinical features at diagnosis.Psychosocial morbidity in acromegaly: a study from India.Diagnostic delay is associated with psychosocial impairment in acromegaly.Safety of long-term treatment with Pegvisomant: analysis of Spanish patients included in global ACROSTUDY.Impact of pre-treatment with somatostatin analogs on surgical management of acromegalic patients referred to a single center.Preoperative lanreotide treatment for GH-secreting pituitary adenomas: effect on tumour volume and predictive factors of significant tumour shrinkage.Clinical-biochemical correlations in acromegaly at diagnosis and the real prevalence of biochemically discordant disease.Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK).Acromegaly: correlation between expression of somatostatin receptor subtypes and response to octreotide-lar treatment.Cost-effectiveness analysis of somatostatin analogues in the treatment of acromegaly in Brazil.Insulin-like growth factor-1 is essential to the increased mortality caused by excess growth hormone: a case of thyroid cancer and non-Hodgkin's lymphoma in a patient with pituitary acromegaly.Changes in acromegaly treatment over four decades in Spain: analysis of the Spanish Acromegaly Registry (REA).High prevalence of eating disorders not otherwise specified in northwestern Spain: population-based study.Cost of clinical management of acromegaly in Spain.Glucose homeostasis in patients with acromegaly treated with surgery or somatostatin analogues.Hematologic neoplasias and acromegaly.
P2860
Q24796554-53D74E19-07D6-41D9-9C8E-619B27CDBC6FQ28076665-C388AE60-A11F-4274-AEC0-E2AF7C6DC22BQ30244550-46A815E6-D852-4B9E-9560-3A2F7BBE9B27Q30632833-42EA71CC-D419-405B-B8B6-8D131BB41642Q33772673-E0D83173-6472-4BE5-9798-3BFFD8E74DBEQ33856407-2834F607-BAF0-4E0C-94B8-95524196F87CQ33950669-9D065133-9228-4F25-ACFD-163CD2C5B920Q34658946-37E2C766-7EC2-4642-9CB9-FFB1712E7686Q34729995-D5BC7671-22C8-4A70-9300-2BDF5ED4F832Q34839608-B93AC778-B2C5-42F6-A0C1-C40F07C08DDBQ35912471-3F5236E2-3EBC-45F3-8513-3E165E650299Q36136921-FB185696-F118-4A41-BCF0-694892510AA8Q36301564-A7FB29CA-9D5B-466C-806F-50374FE43F7AQ36380875-970A90F6-2708-4ECB-8B10-252D7E8F69CAQ36386450-FD0A8863-F1C4-4A31-B7B3-22D477BE6B4AQ36874730-2F3060EC-1811-4804-9F2B-FF6146ADFC38Q36880794-B7A4457B-EA1C-4D4B-BA04-522829090A7DQ36909002-D1E5A417-30D3-463E-9FC9-1D888C8DE1ECQ36937812-A5A1B95E-134B-430F-BE74-F097D4F96BF2Q37030617-F9FDB4CD-3F62-48DA-A77F-F28E42E1B4B8Q37050111-16B96E6B-3872-4007-9D4F-5511F021A1B0Q37072576-F93939CC-F8E7-40AB-93E4-2272D8D4DD80Q37277410-3A892838-64D9-431C-A3FF-0F3CDBED4295Q38176659-7782814E-B60A-4B82-A881-5332A464435EQ38998304-291A72ED-A8F1-486F-AF3E-19F359700B54Q39860125-A1F58780-AEC4-4B22-9E1A-9361D9A66FA6Q40076638-E5095FC9-732F-4C46-BBAC-2AD2673F2858Q40339066-E9852825-497E-4604-9111-6699BDA5CCA2Q40931422-D0EEF2C2-036E-45D8-B773-0D34C1BB4154Q42438405-1910B8A2-DB68-4632-9B3B-0ECAC446E69EQ42470520-542AF8EE-6B66-4C1A-B6F5-EB0A78E8F182Q44314621-A02A2832-5591-4BE9-9681-C979DDFBEE83Q46069930-38550F85-9AB4-498B-A3A2-E4E798ADBFD4Q46131356-47439BD7-804B-4C0F-B4D0-5294CD0C8E56Q46457866-50C087A5-F0EA-48A3-A02E-2165CF7714DAQ47936712-4FBB4EEA-F861-44B8-A062-9E84B3364486Q50773244-497AE63A-FF69-431A-834A-C1C4B83B311FQ51180663-56E04672-A429-4B2E-9E16-2D3AFC3D4C6CQ51374462-11F7425F-DD1B-4D3C-807A-434F96A2D04BQ53403062-EA77E5A6-9824-4F5B-9981-CD22AD251CCA
P2860
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh
1993年學術文章
@zh-hant
name
Acromegaly: an epidemiological study.
@en
Acromegaly: an epidemiological study.
@nl
type
label
Acromegaly: an epidemiological study.
@en
Acromegaly: an epidemiological study.
@nl
prefLabel
Acromegaly: an epidemiological study.
@en
Acromegaly: an epidemiological study.
@nl
P2093
P2860
P356
P1476
Acromegaly: an epidemiological study.
@en
P2093
J A Vazquez
S Gaztambide
P2860
P2888
P304
P356
10.1007/BF03344942
P577
1993-03-01T00:00:00Z
P6179
1047412630